For the readers interested in the stock health of Gamida Cell Ltd. (GMDA). It is currently valued at $12.43. When the transactions were called off in the previous session, Stock hit the highs of $15.00, after setting-off with the price of $14.24. Company’s stock value dipped to $12.07 during the trading on the day. When the trading was stopped its value was $9.89.
Recently in News on February 9, 2021, Gamida Cell Presents Efficacy and Safety Results of Phase 3 Study of Omidubicel in Patients with Hematologic Malignancies at the 2021 TCT Meetings of ASTCT and CIBMTR. — Omidubicel represents a potentially transformative cell therapy treatment option for patients in need of a bone marrow transplant —. You can read further details here
Gamida Cell Ltd. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $15.00 on 02/10/21, with the lowest value was $7.77 for the same time period, recorded on 02/01/21.
Gamida Cell Ltd. (GMDA) full year performance was 163.35%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Gamida Cell Ltd. shares are logging 10.98% during the 52-week period from high price, and 378.08% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.60 and $11.20.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 11679370 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Gamida Cell Ltd. (GMDA) recorded performance in the market was 48.15%, having the revenues showcasing 114.68% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 704.16M, as it employees total of 79 workers.
Analysts verdict on Gamida Cell Ltd. (GMDA)
During the last month, 7 analysts gave the Gamida Cell Ltd. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.16, with a change in the price was noted +8.13. In a similar fashion, Gamida Cell Ltd. posted a movement of +189.07% for the period of last 100 days, recording 799,401 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for GMDA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Gamida Cell Ltd. (GMDA): Technical Analysis
Raw Stochastic average of Gamida Cell Ltd. in the period of last 50 days is set at 69.91%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 64.45%. In the last 20 days, the company’s Stochastic %K was 69.50% and its Stochastic %D was recorded 74.13%.
Let’s take a glance in the erstwhile performances of Gamida Cell Ltd., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 48.15%. Additionally, trading for the stock in the period of the last six months notably improved by 199.52%, alongside a boost of 163.35% for the period of the last 12 months. The shares increased approximately by 30.29% in the 7-day charts and went down by 39.82% in the period of the last 30 days. Common stock shares were driven by 114.68% during last recorded quarter.